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he Impact of Transcatheter Atrial Septal Defect
losure in the Older Population
Prospective Study
rif Anis Khan, MD,* Ju-Le Tan, MD,*† W. Li, PHD,* Kostas Dimopoulos, MD, PHD,*
ark S. Spence, MD,*‡ Pak Chow, MD,*§ Michael J. Mullen, MD*
ondon, United Kingdom; Mistri Wing, Singapore; Belfast, Ireland; and Hong Kong, China
bjectives We sought to prove that device closure of atrial septal defect (ASD) in older patients
ot only improves cardiac function but also results in symptomatic relief by improving functional
lass.
ackground Atrial septal defect accounts for approximately 10% of all congenital cardiac defects.
t is possible that ASD closure in older patients may derive beneﬁts, though this is not well estab-
ished. We therefore aim to prospectively assess the clinical status and functional class of older pa-
ients after transcatheter ASD closure.
ethods This was a prospective study of all patients age 40 years or more who underwent device
losure of a secundum ASD between April 2004 and August 2006. Investigations including atrial and
rain natriuretic peptide levels, electrocardiography, chest X-ray, transthoracic echocardiogram,
-min walk test, and quality of life questionnaire were performed before and at 6 weeks and 1 year
fter the procedure.
esults Twenty-three patients (median age 70 years, 13 women) had transcatheter device closure
f ASD. Median ASD size was 18 mm (range 9 to 30 mm). Median pulmonary artery pressure was
2 mm Hg (range 12 to 27 mm Hg). At 1 year, New York Heart Association functional class im-
roved (p  0.004) in 16 patients with signiﬁcant improvement in 6-min walk-test distance (p 
.004) and physical (p  0.002) as well as mental health score (p  0.03). There were no major
omplications. One year following closure there was a signiﬁcant change in left ventricular end-dia-
tolic (p  0.001) and end-systolic dimensions (p  0.001) and also signiﬁcant reduction in right
entricular end-diastolic dimension (p  0.001).
onclusions Our data demonstrated that ASD closure at advanced age results in favorable cardiac
emodeling and improvement of functional class. (J Am Coll Cardiol Intv 2010;3:276–81) © 2010
y the American College of Cardiology Foundation
rom the *Royal Brompton Hospital, London, United Kingdom; †National Heart Centre Singapore, Mistri Wing, Singapore;
Royal Victoria hospitals, Belfast, Ireland; and the §Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.anuscript received November 17, 2009, accepted December 13, 2009.
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277trial septal defect (ASD) is one of the most common forms
f congenital heart disease in adults (1), accounting for approx-
mately 10% of all congenital cardiac defects (2,3). The left-to-
ight shunt through an ASD results in chronic volume overload of
he right heart and, if untreated, may lead to atrial arrhythmias (4),
ight heart failure (5,6), pulmonary hypertension (7), and/or
ystemic embolism (8). Closure of ASD in children and young
dults is recommended with low operative risk and a good
ong-term prognosis (9–11). Adults with an ASD, although
ften reporting no symptoms or only mild effort intolerance,
ay have a significant reduction in cardiopulmonary function
uring formal exercise testing (12–14). However the benefits of
SD closure in older patients are less clear (15–19), and closure of
he defect may be delayed or withheld (20). We therefore
rospectively assessed the effects of transcatheter ASD closure
n clinical and echocardiographic parameters in older patients.
ethods
tudy population. We prospectively studied consecutive pa-
ients age 40 years who underwent device closure of a
ecundum ASD at the Royal Brompton Hospital, London,
etween April 2004 and August 2006. Patients listed for device
losure were those with hemodynamically significant secun-
um ASD defined by the presence of right heart dilation and
ignificant left to right shunt with calculated Q p/Q s ratio
1.5 on echocardiogram. The study was approved by the
nstitutional ethics committee and patients provided informed
onsent before participation in the study. Only those patients
nable to perform an exercise test or who declined to give
onsent were excluded from the study.
evice closure. Transcatheter ASD closure was performed
s previously described (21). The Amplatzer septal occluder
AGA Medical, Plymouth, Minnesota) was used in all
atients. The Amplatzer septal occluder device size was
elected using balloon sizing or intraprocedural echocardio-
raphic assessment of ASD diameter as previously described
22,23).
tudy protocol. The following evaluations were performed
mmediately before ASD closure and at 6 weeks and 1 year
fter the procedure: full blood count, serum atrial natriuretic
eptide and brain natriuretic peptide (24) levels determined
y immunoradiometric assay, 12-lead electrocardiogram,
hest X-ray, transthoracic echocardiogram, and 6-min walk
est (6MWT). Quality of life (QOL) was assessed using the
ealth survey and New York Heart Association (NYHA)
unctional class.
Transthoracic echocardiographic studies were performed
ccording to the American Society of Echocardiography
uidelines (25). Left ventricle (LV) M-mode measurements
nd right ventricular (RV) diastolic dimensions were made
n parasternal long-axis view and RV inlet measurement in
he apical 4-chamber view. Ventricular filling was assessed
sing pulse-wave Doppler, with the sample volume posi- aioned at the level of the tricuspid and mitral valve tips,
ncluding deceleration time analysis. Doppler tissue imaging
DTI) was performed and both systolic (s) and diastolic
aves, early (e) and atrial (a), were recorded at the tricuspid
nd mitral valve annular level. Left and right atrial volumes
ere measured by planimetry in 4-chamber view.
Quality of life (QOL) was assessed using the SF-36v2
ealth Survey (2nd version) (QualityMetric, Inc., Lincoln,
hode Island). This health survey was used for the first time
o assess health-related QOL outcomes after ASD closure.
his questionnaire has been suggested for the evaluation of
wide variety of medical interventions (26), as it is not
isease- or treatment-specific (27). Each questionnaire was
iven to the patient for an hour to complete, and data were
ntered into a Web-based patient tracking service.
tatistical analysis. R version 2.9.2 (AT&T Bell Labora-
ories, Murray Hill, New Jersey), with packages nlme and
lmmAK was used for statistical calculations. Data are
xpressed as mean  SD, or median with range, as appropri-
te. Changes in the continuous parameters over time were
nalyzed using a mixed-model linear regression analysis,
ith patients as a random effect
nd time as a fixed effect. Change
n functional (NYHA) class was
ssessed using a cumulative logit
odel for ordinal response
MCMC sampling, 40,000 itera-
ions, burn-in 10,000). A p value
0.05 was considered statistically
ignificant.
esults
total of 23 patients (13 women; median age 68 years, range
0 to 91 years) underwent ASD closure (Table 1). Median
SD size was 18 mm (range 9 to 30 mm) and median device
ize was 24 mm (range 16 to 36 mm). Median Q p/Q s ratio
as 2.2 (range 1.5 to 3). Median pulmonary artery pressure was
3 mm Hg (range 12 to 27 mm Hg). Three patients had mean
ulmonary artery pressures25 mm Hg. None of the patients
howed signs of pulmonary hypertension at 1-year follow-up
chocardiogram.
Device delivery and implantation were successful without
rocedure-related complications in all patients. Five pa-
ients (21%) were in atrial fibrillation at the time of
mplantation. One patient developed transient atrial fibril-
ation after the procedure that reverted to sinus rhythm after
reatment with flecainide. Two patients had 2 devices
mplanted at the same procedure due to the presence of
ultiple defects. Four patients had minor groin hematoma
t the puncture site. One patient developed chronic renal
ailure and died suddenly 24 weeks after device closure from
Abbreviations and
Acronyms
6MWT  6-min walk test
ASD  atrial septal defect
DTI  Doppler tissue imaging
LV  left ventricle
NYHA  New York Heart
Association
QOL  quality of life
RV  right ventriclen unexplained cause.
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278At baseline, 16 (70%) patients were in NYHA functional
lass II and 5 (22%) were in NYHA class III and average
MWT distance was 400 m. Following ASD closure, a
ignificant improvement in 6MWT distance (Fig. 1) was
bserved (94-m increase in average at 1 year [p  0.001]).
his was associated with an improvement in NYHA class,
resent as early as 6 weeks and maintained at 1-year
ollow-up (NYHA I: 77%, 17 of 22, p  0.0001) (Table 2).
Low SF-36v2 survey scores were obtained at baseline for
ental and physical health (Table 2) in our population, with
lmost two-thirds of patients scoring well below average in
oth (28). A significant improvement in both the mental (p
.007) and physical score (p 0.001) was seen over the period
f 1 year after the procedure. At 1 year, only 13 of mental and
hysical scores were below average.
Comparison of RV and LV dimensions are as shown in
igure 2. Right ventricular end-diastolic and inlet dimen-
Figure 1. Improvement in 6MWT
Table 1. General Characteristics of Patients
No. of patients 23
Mean age, yrs 69 (43–92)
Sex, M/F 10/13
Hypertension 7 (30)
Hypercholesterolemia 6 (26)
Ischemic heart disease 3 (13)
Chronic renal failure 1 (4)
ASD size, mm 18 (9–30)
ASO device size, mm 24 (10–36)
Mean PA pressure, mm Hg 22 (12–27)
Qp/Qs ratio 2.2 (1.5–3)
Procedure time, min 65 (41–110)
Fluoroscopic time, min 14.6 (7–33)
Values are n (%), median (range), or n.
ASD  atrial septal defect; ASO  Amplatzer septal occluder; PA  pulmonary artery; Qp 
pulmonary flow; Qs systemic flow.t
Improvement in 6-min walk test distance (6MWTD) (p  0.0001).ions, as well as right atrial volume decreased significantly
p  0.001 for all) (Table 3). No significant change in
ricuspid annular plane systolic excursion was found. Right
entricular DTI data are also shown in Table 3; similarly,
ystolic DTI velocities at tricuspid annular level did not
how any significant improvement.
There was a significant increase in LV end-diastolic and
nd-systolic dimensions after ASD closure (Table 4), with
he greatest change seen in the first 6 weeks. Similarly, there
as significant improvement in global LV systolic function
mean LV ejection fraction: 65%, 76%, and 82%, pre-
losure, at 6 weeks, and at 1 year, respectively, p  0.0001).
here was a borderline reduction in LV long-axis function
ith no reduction in systolic DTI velocities. After an initial
ise in atrial natriuretic peptide levels at 6 weeks, this
ecreased at 1 year, albeit not reaching statistical signifi-
ance (Fig. 3).
iscussion
n this study, we have demonstrated that ASD closure is
echnically feasible with a high success rate and can be
erformed at low risk in the older population. We observed
ignificant improvement in symptoms and functional ability
ith favorable cardiac remodeling in an older population
fter transcatheter ASD closure. The most clinically rele-
ant finding of our study was the increase in exercise
apacity as indicated by the 23.5% increase in 6MWT
istance and the improvement in QOL as assessed by the
F-36v2 survey and NYHA functional class.
Closure of ASD is often considered nonbeneficial in older
atients because few data exist on symptomatic relief gained
fter device closure in older patients. Our study provides
urther evidence that transcatheter device closure of ASD in
dults over the age of 40 years is not only safe and effective,
ut also results in symptomatic relief by improving func-
Table 2. Changes in Health Status, Rhythm, and Cardiothoracic Ratio
Pre-Closure
(n  23)
6 Weeks
(n  23)
1 Year
(n  22) p Value
NYHA functional class 0.0001
I 2 (9%) 11 (48%) 17 (78%)
II 16 (70%) 9 (39%) 3 (13%)
III 5 (22%) 3 (13%) 2 (9%)
QOL
Mental health score 46 10.7 47 10.8 53 5.1 0.007
Physical health score 47 6.7 48 7.4 53.8 5.1 0.0001
6MWT distance, m 400 106 451 102 493 89 0.001
CT ratio 0.57 0.05 0.56 0.06 0.54 0.07 ns
QRS duration, ms 108 40 106 45 106 17 ns
CT  cardiothoracic; NYHA  New York Heart Association; QOL  quality of life; 6MWT 
6-min walk test.ional class and 6MWT distance with favorable cardiac
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279emodeling. Our study group has shown significant im-
rovement in both 6MWT distance and NYHA class after
SD closure. The 6MWT is a simple clinical tool, which is
seful in the serial evaluation of patient status (29,30). In
ighly symptomatic patients, it provides information similar
o cardiopulmonary exercise testing and has an independent
rognostic value (31). Similarly, NYHA functional class is
lso a predictor of survival in heart failure patients (32).
Our study group mostly had less than average mental and
hysical health scores, and this reflects the compromised
unctional status at baseline. Both of these scores showed
ignificant improvement over the 1-year period.
We demonstrated that despite longstanding RV dilation
rom volume overloading, there is still potential for im-
rovement in RV size and possible improvement in func-
ions (33) even at an advanced age. Closure of ASD resulted
n cardiac remodeling with a significant reversal of the right
o left volumetric imbalance. These changes were evident
ithin a few weeks following closure and continued at 1
Figure 2. Comparison of LV and RV Diastolic Dimensions
Comparison of left ventricular (LV) (p  0.001) and right ventricular (RV) (p 
RVEDD  right ventricular end-diastolic dimension.
Table 3. Changes in RV Echocardiographic Parameters
Pre-Closure
(n  23)
6 Weeks
(n  23)
1 Year
(n  22) p Value
RVDD, mm 36 8 34.2 6.3 26.9 4.5 0.0001
RV inlet, mm 48 8.1 45.6 9.8 33 4.5 0.0001
RA volume, ml 126.1 62.4 80.2 45.5 58.9 18.6 0.0004
TAPSE, mm 21.8 5.7 23 4.6 23 3.2 0.51
DTI RV, cm/s
s 13.6 2.8 12 3.3 12.9 3.3 0.09
e 9.1 2.5 8.9 2.5 9.8 2.9 0.61
a 15 3.2 13.2 5.3 12.4 3.3 0.03
a  atrial wave; DTI  Doppler tissue imaging; e  early wave; RA  right atrium; RV  right
ventricle; RVDD  right ventricular diastolic dimension; s  systolic wave; TAPSE  tricuspidannular plane systolic excursion.ear. Pascotto et al. (10,34) has shown that cardiac remod-
ling starts very shortly after transcatheter ASD closure in
elatively young populations (mean age 22  18 years) and
hat most of the cardiac remodeling appeared within a few
eeks of closure. Conversely, in our older study cohort
median age 68 years) we observed that most of the
mprovement in RV size took place beyond 6 weeks from
SD closure.
Left ventricular systolic function also improved soon after
losing the ASD and removing the RV volume overload. In
atients with an ASD, shunting of blood into the right
eart invariably affects LV filling, akin to a “steal phenom-
non.” Our results support the phenomenon of ventricular
nterdependence (35) associated with RV volume overload
nd the “reverse Bernheim’s effect” in which the septum
ulges into the LV cavity leading to impaired LV filling.
ollowing device closure, left to right shunt is abolished and
diastolic dimensions. LVEDD  left ventricular end-diastolic dimension;
Table 4. Changes in LV Echocardiographic Parameters
Pre-Closure
(n  23)
6 Weeks
(n  23)
1 Year
(n  22) p Value
LVEDD, mm 41.4 4.4 48.4 5.2 51 4.2 0.0001
LVESD, mm 26.8 3.4 28.1 4 30.8 4.5 0.0001
LV inlet, mm 38 3.6 39.4 3.2 43 2.8 0.0001
LVEF, % 64.9 8.2 76.4 8.1 82 6.1 0.0001
LA volume, ml 84.3 37.4 80.9 34.6 82.6 34.1 0.53
MAPSE, mm 16.8 3.5 14.9 3.7 14.5 2.6 0.04
DTI LV, cm/s
s 11.9 3.3 9.5 2.5 9.8 2.3 0.10
e 9.9 2 8.6 1.9 9.2 2 0.33
a 12.3 2.9 11.2 3.2 10.4 3.1 0.01
LA  left atrium; LVEDD  left ventricular end-diastolic dimension; LVEF  left ventricular
ejection fraction; LVESD left ventricular end-systolic dimension; MAPSEmitral annular plane0.001)septal excursion; other abbreviations as in Table 3.
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280V filling is improved resulting in an increase in LV
imensions and ejection fraction. A similar trend was found
n a recently published study (36). The improvement in LV
unction was most marked in the first 6 weeks after ASD
losure, suggesting that LV remodeling occurs early and
lateaus thereafter (37).
Improvements in LV function are likely to be a major
eterminant of the early improvement in NYHA functional
lass seen after ASD closure. It is of interest that the
mprovement in LV size and function appears to occur
arlier than in the RV. This may suggest that LV remod-
ling is independent of RV remodeling.
Schubert et al. (38) have shown that ASD closure in some
lderly patients may be associated with a transient increase
n left atrial pressure and subsequent pulmonary edema due
o an underlying “stiff” LV. However, in our cohort, no
ases of pulmonary edema occurred and no significant new
rrhythmias were noted during the 1-year follow-up. Sim-
larly no patient developed signs of diastolic dysfunction or
itral regurgitation following ASD closure. Arrhythmia
ersisted in all patients, when present before the procedure.
No major adverse cardiovascular events related to the
rocedure were observed in the first 3 months after closure
n our patients, which is in contrast to what has been
eported for surgical ASD closure in patients 40 years of
ge (39). In our study, an 81-year-old man died 24 weeks
fter ASD closure, of causes that were unrelated to the
rocedure. His ASD was 21 mm in size and was closed with
4-mm ASO device with no technical difficulty. He was in
YHA class III before the closure. He was last reviewed 18
eeks before his death. At that time, he was in NYHA class
I and his health scores had also shown improvement from
aseline. Echocardiogram at that time showed a well-placed
Figure 3. Change in ANP and BNP Over 1 Year
Change in atrial natriuretic peptide (ANP) (p  0.11) and brain natriuretic pepevice without any complications. He had chronic atrialbrillation and chronic renal failure and had been on
emodialysis for the last 4 years. A necropsy examination
as not performed, and his death was presumed to have
een caused by myocardial infarction.
tudy limitations. This was a nonrandomized single-center
ohort study, on a relatively small group of consecutive
atients undergoing percutaneous ASD closure. Larger,
andomized comparisons are required to establish the effi-
acy of ASD closure in this older adult population.
onclusions
ur data demonstrate that transcatheter ASD closure is
echnically feasible and results in favorable cardiac remod-
ling and significant improvement in functional class and
OL in older patients.
eprint requests and correspondence: Dr. Arif Anis Khan, MD,
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